Suppr超能文献

通过定量磁化率成像测量早期特发性帕金森病中特定区域铁分布紊乱情况

Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

作者信息

He Naying, Ling Huawei, Ding Bei, Huang Juan, Zhang Yong, Zhang Zhongping, Liu Chunlei, Chen Kemin, Yan Fuhua

机构信息

Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

MR Research, GE Healthcare, Shanghai, China.

出版信息

Hum Brain Mapp. 2015 Nov;36(11):4407-20. doi: 10.1002/hbm.22928. Epub 2015 Aug 7.

Abstract

In Parkinson's disease (PD), iron elevation in specific brain regions as well as selective loss of dopaminergic neurons is a major pathologic feature. A reliable quantitative measure of iron deposition is a potential biomarker for PD and may contribute to the investigation of iron-mediated PD. The primary purpose of this study is to assess iron variations in multiple deep grey matter nuclei in early PD with a novel MRI technique, quantitative susceptibility mapping (QSM). The inter-group differences of susceptibility and R2* value in deep grey matter nuclei, namely head of caudate nucleus (CN), putamen (PUT), global pallidus (GP), substantia nigra (SN), and red nucleus (RN), and the correlations between regional iron deposition and the clinical features were explored in forty-four early PD patients and 35 gender and age-matched healthy controls. Susceptibility values were found to be elevated within bilateral SN and RN contralateral to the most affected limb in early PD compared with healthy controls (HCs). The finding of increased susceptibility in bilateral SN is consistent with work on a subgroup of patients at the earliest clinical detectable state (Hoehn and Yahr [1967]: Neurology 17:427-442; Stage I). However, increased R2* values were only seen within SN contralateral to the most affected limb in the PD group when compared with controls. Furthermore, bilateral SN magnetic susceptibility positively correlated with disease duration and UPDRS-III scores in early PD. This finding supports the potential value of QSM as a non-invasive quantitative biomarker of early PD.

摘要

在帕金森病(PD)中,特定脑区铁含量升高以及多巴胺能神经元的选择性丧失是主要的病理特征。铁沉积的可靠定量测量是PD的潜在生物标志物,可能有助于铁介导的PD的研究。本研究的主要目的是采用一种新的MRI技术——定量磁化率成像(QSM),评估早期PD患者多个深部灰质核团中的铁含量变化。在44例早期PD患者和35例年龄及性别匹配的健康对照中,探讨了深部灰质核团(即尾状核头部(CN)、壳核(PUT)、苍白球(GP)、黑质(SN)和红核(RN))的磁化率和R2值的组间差异,以及区域铁沉积与临床特征之间的相关性。与健康对照(HCs)相比,发现早期PD患者中,双侧SN和与最受影响肢体对侧的RN内的磁化率值升高。双侧SN磁化率升高这一发现与最早临床可检测状态(Hoehn和Yahr [1967]:《神经病学》17:427 - 442;I期)的一组患者的研究结果一致。然而,与对照组相比,PD组中仅在与最受影响肢体对侧的SN内观察到R2值升高。此外,早期PD患者中双侧SN磁化率与病程和统一帕金森病评定量表第三部分(UPDRS - III)评分呈正相关。这一发现支持了QSM作为早期PD的非侵入性定量生物标志物的潜在价值。

相似文献

2
Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
BMC Neurosci. 2019 May 22;20(1):23. doi: 10.1186/s12868-019-0505-9.
3
Quantitative Susceptibility Mapping in Parkinson's Disease.
PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016.
4
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
5
Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Neurol India. 2020 Mar-Apr;68(2):278-281. doi: 10.4103/0028-3886.284377.
7
Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Eur Radiol. 2024 May;34(5):3074-3083. doi: 10.1007/s00330-023-10283-1. Epub 2023 Oct 19.
8
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
9
Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Neuroimage Clin. 2021;32:102831. doi: 10.1016/j.nicl.2021.102831. Epub 2021 Sep 22.
10
Age and sex related differences in subcortical brain iron concentrations among healthy adults.
Neuroimage. 2015 Nov 15;122:385-98. doi: 10.1016/j.neuroimage.2015.07.050. Epub 2015 Jul 26.

引用本文的文献

1
5
High-resolution mapping of substantia nigra in Parkinson's disease using 7 tesla magnetic resonance imaging.
NPJ Parkinsons Dis. 2025 May 6;11(1):113. doi: 10.1038/s41531-025-00972-7.
6
Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies.
Brain Sci. 2025 Apr 6;15(4):380. doi: 10.3390/brainsci15040380.
8
Midbrain and pallidal iron changes identify patients with REM sleep behaviour disorder and Parkinson's disease.
NPJ Parkinsons Dis. 2025 Apr 23;11(1):84. doi: 10.1038/s41531-025-00916-1.
9
Sensitivity of Quantitative Susceptibility Mapping for Clinical Research in Deep Gray Matter.
Hum Brain Mapp. 2025 Apr 15;46(6):e70187. doi: 10.1002/hbm.70187.
10
Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies.
CNS Neurosci Ther. 2025 Mar;31(3):e70359. doi: 10.1111/cns.70359.

本文引用的文献

2
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
Neuroimage. 2015 Mar;108:111-22. doi: 10.1016/j.neuroimage.2014.12.043. Epub 2014 Dec 20.
3
Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults.
Neuroimage. 2015 Jan 15;105:45-52. doi: 10.1016/j.neuroimage.2014.10.009. Epub 2014 Oct 12.
5
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. doi: 10.1089/ars.2013.5593. Epub 2014 Feb 6.
6
Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.
Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019. Epub 2013 Oct 8.
7
Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan.
Hum Brain Mapp. 2014 Jun;35(6):2698-713. doi: 10.1002/hbm.22360. Epub 2013 Sep 13.
8
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
Neurology. 2013 Aug 6;81(6):534-40. doi: 10.1212/WNL.0b013e31829e6fd2. Epub 2013 Jul 10.
9
Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
Radiology. 2013 Oct;269(1):216-23. doi: 10.1148/radiol.13121991. Epub 2013 May 14.
10
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.
Ann Neurol. 2013 Apr;73(4):554-9. doi: 10.1002/ana.23817. Epub 2013 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验